Medicure Stock Performance
| MCUJF Stock | USD 0.88 0.07 8.64% |
On a scale of 0 to 100, Medicure holds a performance score of 9. The company secures a Beta (Market Risk) of 1.59, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medicure will likely underperform. Please check Medicure's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Medicure's current price movements will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Medicure are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating forward-looking indicators, Medicure reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.7 M | |
| Total Cashflows From Investing Activities | -2.7 M |
Medicure |
Medicure Relative Risk vs. Return Landscape
If you would invest 66.00 in Medicure on April 26, 2025 and sell it today you would earn a total of 22.00 from holding Medicure or generate 33.33% return on investment over 90 days. Medicure is currently producing 0.5564% returns and takes up 4.4354% volatility of returns over 90 trading days. Put another way, 39% of traded pink sheets are less volatile than Medicure, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medicure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicure's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medicure, and traders can use it to determine the average amount a Medicure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1254
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MCUJF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.44 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Medicure is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicure by adding it to a well-diversified portfolio.
Medicure Fundamentals Growth
Medicure Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medicure, and Medicure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medicure Pink Sheet performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.67 M | |||
| Shares Outstanding | 10.25 M | |||
| Price To Earning | 11.45 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.37 X | |||
| Revenue | 21.74 M | |||
| EBITDA | 2.42 M | |||
| Cash And Equivalents | 4.83 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 1.02 M | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 2.04 X | |||
| Cash Flow From Operations | 3.99 M | |||
| Earnings Per Share | 0.21 X | |||
| Total Asset | 28.41 M | |||
| Retained Earnings | (89.95 M) | |||
| Current Asset | 12.56 M | |||
| Current Liabilities | 7.45 M | |||
About Medicure Performance
By analyzing Medicure's fundamental ratios, stakeholders can gain valuable insights into Medicure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medicure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medicure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.Things to note about Medicure performance evaluation
Checking the ongoing alerts about Medicure for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medicure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medicure has some characteristics of a very speculative penny stock | |
| Medicure appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 21.74 M. Net Loss for the year was (727 K) with profit before overhead, payroll, taxes, and interest of 12.71 M. | |
| About 27.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medicure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medicure's stock is overvalued or undervalued compared to its peers.
- Examining Medicure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medicure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medicure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medicure's pink sheet. These opinions can provide insight into Medicure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medicure Pink Sheet analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance |